PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom - Samyshkin, Y.; Hertel, N.; Griebsch, I. (Value in Health, 2011)